Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCERTAIN: ASTX727 vs IV Decitabine in MDS, CMML, and AML
NCT03306264Phase 3Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Feb 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of inqovi in myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), acute myeloid leukemia (AML), sponsored by Astex Pharmaceuticals. Started Feb 2018; status: completed.
02
Drugs
inqovi
03
Conditions
myelodysplastic syndrome (MDS)chronic myelomonocytic leukemia (CMML)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03306264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03306264.